ARCHIVES

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997

NCI, Litton Open Talks On Frederick Contract

February 6, 1976

Greenwald Lists Plans For $40 Million Raise In Prevention & Control

December 3, 1993

Federal Hospitals Should Share Radiotherapy Facilitates: GAO

February 16, 1979

Karlan To Succeed Hoskins As Chairman, DOD Ovarian Cancer Program Advisory Panel.

July 27, 2001